Inferior vena cava filters have increasingly been used in patients with acute venous thromboembolism over the past 3 decades, despite a lack of long-term data on their benefits and risks. A new ...

BOTHELL, Wash.--(BUSINESS WIRE)--BTG plc (LSE: BTG), the global healthcare company, highlighted the presentation of the two-year results for the SENTRY trial, at the Vascular Interventional Advances ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

Despite clinical trial data showing inferior vena cava (IVC) filters are ineffective for reducing mortality following deep vein thrombosis (DVT), as well as guideline recommendations against their use ...

Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters—devices used to keep blood clots ...

Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...

BLOOMINGTON, Ind.--(BUSINESS WIRE)--On January 6, Cook announced that the United States District Court for the Southern District of Indiana vacated in its entirety a February 1, 2019, judgment against ...

Use of inferior vena cava (IVC) filters appears to offer no mortality benefit — and may confer a mortality risk — in older adults with pulmonary embolism (PE), a study has shown. The results of the ...

(HealthDay)—The rates of inferior vena cava (IVC) filter placement increased from 2005 until 2010 and then decreased through 2014, according to a research letter published online Nov. 6 in JAMA ...

Two medical device companies that were hit last month with a $33 million verdict over their allegedly defective blood filter devices are seeking to have the award overturned. Rex Medical and Argon ...